Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer.

Ten Thoren, C

Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer. [electronic resource] - The European journal of health economics : HEPAC : health economics in prevention and care Aug 2020 - 881-893 p. digital

Publication Type: Journal Article

1618-7601

10.1007/s10198-020-01180-1 doi


Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Databases, Factual
Drug Approval--methods
Germany
Humans
Lung Neoplasms--drug therapy
Technology Assessment, Biomedical